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Skin pigmentation is dependent on cellular processes including melanosome biogenesis,
transport, maturation and transfer to keratinocytes. However, how the cells finely control
these processes in space and time to ensure proper pigmentation remains unclear. Here, we
show that a component of the cytoplasmic dynein complex, Dynlt3, is required for efficient
melanosome transport, acidity and transfer. In Mus musculus melanocytes with decreased
levels of Dynlt3, pigmented melanosomes undergo a more directional motion, leading to their
peripheral location in the cell. Stage IV melanosomes are more acidic, but still heavily pig-
mented, resulting in a less efficient melanosome transfer. Finally, the level of Dynlt3 is
dependent on β-catenin activity, revealing a function of the Wnt/β-catenin signalling pathway
during melanocyte and skin pigmentation, by coupling the transport, positioning and acidity
of melanosomes required for their transfer.
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Melanocytes are neural crest-derived cells that are pri-marily found in the epidermis and hair follicles but arealso found in the inner ear, eye, heart, and meninges1.
These cells contain specialized organelles, known as melano-
somes, which are responsible for pigmentation. Melanosomes
belong to the lysosome-related organelle (LRO) family and exist
in four different stages2. Only stage III and IV melanosomes are
pigmented. Stage I melanosomes, the most primitive melano-
somes, are membrane-bound early endosomal structures that
initiate the intraluminal Pmel fibrillation. Pmel, a melanosomal
protein, forms a fibrillar network in the lumen of the melano-
some, upon which melanin is eventually deposited after its
synthesis. The Pmel fibrils are fully formed in stage II melano-
somes, following which melanin synthesis begins. In stage III,
different melanogenesis enzymes (e.g., Tyrp1, Dct) are trans-
ported and inserted into the melanosome limiting membrane to
produce melanin, which deposits on the pre-existing Pmel fibrils.
Melanin accumulates in stage IV melanosomes that will become
heavily pigmented. Melanosomes/melanin are then transferred to
keratinocytes through an exocytosis/phagocytosis process to fulfill
their primary role in protecting the skin from UV irradiation3.
Prior to melanosome exocytosis and melanin transfer, melano-
somes must acquire a secretory signature through maturation
steps that are still poorly understood. Maturation is a complex
process that includes the melanosome lumen deacidification
or neutralization, the acquisition of specific endosomal compo-
nents by the melanosomes, and the concomitant removal of
melanosome-associated membrane proteins (Vamp7 and most
likely Tyrp1) through the generation and release of melanosomal
membrane tubules4–6.
The intracellular trafficking of melanosomes, similar to other
LROs, involves the action of different families of motor proteins.
Along the microtubules, melanosomes are transported by both
kinesin and dynein motors7. Most kinesins move their respective
cargoes from the nucleus towards the periphery, with kinesin I
and II thought to be involved in this centrifugal melanosome
movement8,9. Conversely, dynein motors move their cargoes in
the opposite direction, centripetally towards the cell center10. At
the cell periphery, melanosomes are transferred to the actin
microfilaments, where the complex consisting of Myosin Va,
Rab27a, and Melanophilin move the melanosomes centrifugally7
to be transferred. While mutations in these three genes lead to
pigmentation defects in humans11–13 and in mice14–16, to date,
no mutation in dynein and kinesin genes has been described in
pigmentation.
The cytoplasmic dynein complex is a macromolecular structure
composed of six different subunits: heavy chains, intermediate
chains, light intermediate chains, and three families of light
chains, including Dynlt3, all of which are present in two copies17.
This protein complex is activated by binding to different cofactor
proteins, such as dynactin18. The heavy chains comprise the
globular domain which physically interacts with microtubules to
generate forward motion through ATP hydrolysis. The inter-
mediate, light intermediate, and light chains interact either
directly or indirectly with the heavy chains, bind to activating
cofactors such as dynactin, and have a role in cargo recognition
and specificity19,20. While all of the specific dynein proteins
involved in the recognition of melanosomes remain unclear,
previous studies using human melanocytes in culture have
demonstrated that the cytoplasmic heavy chain (DYNC1H1) and
a 74 kDa intermediate chain are expressed in melanocytes and are
implicated in melanosome centripetal movement, whereas studies
using Xenopus melanophores have implicated the light inter-
mediate chain 1 dynein (Dync1li1) in these processes21–23.
Dynlt3 belongs to the Tctex family of light chains and is
homologous to Dynlt1, although these two family members are
not often expressed in the same tissues24,25. While no intracel-
lular cargo has been identified for Dynlt3, it is known to interact
with viral proteins during infection (e.g., Herpes Simplex virus
capsid protein VP2626), Dynlt3 also has a role in the regulation of
the spindle checkpoint through its interactions with the check-
point protein Bub327. Interestingly, Dynlt3 can also be localized
to the nucleus, where it interacts with the chromatin remodeler
SATB1 and is involved in SATB1-mediated repression of the
BCL2 gene28.
β-catenin is a multi-functional protein that is involved in
cell–cell adhesion, cell signaling, and transcriptional regulation.
At the cell membrane, β-catenin interacts with the cytoplasmic
domain of classical cadherins (e.g., E-, N-, P-cadherin) and with
α-catenin, and is a pivotal component of the adherens junction29.
The levels of cytoplasmic β-catenin can be affected by a number
of signaling pathways, most notably the Wnt pathway30. In the
nucleus, β-catenin interacts with transcriptional regulators (such
as Lef/Tcf, Foxo, Smad30) to modulate gene expression. In
the melanocyte lineage, it has been shown to directly influence
melanocyte differentiation by inducing M-MITF or BRN2
expression31,32.
In humans and mice, abnormal skin pigmentation results from
a reduction/lack of melanocytes, a defect in melanin synthesis,
and/or disrupted melanosome transport/maturation/transfer33.
Using bcat* mice, which express a mutant, stable β-catenin in the
melanocyte lineage, we have previously shown that increased,
melanocyte-specific β-catenin activity resulted in a lighter coat
color phenotype34. Furthermore, loss of β-catenin in the mela-
nocyte lineage, using Tyr::Cre/°; βcat Δex2-6F/F mice, resulted in a
major reduction of melanocyte proliferation and a coat color
phenotype in mice35. While β-catenin clearly affects pigmenta-
tion, its role in regulating melanosome dynamics has, until now,
remained unknown.
In the current study, using melanocyte cell lines established
from the skin of wild-type and bcat* C57BL/6J mice in culture,
we observed a marked diminution in the number of pigmented
melanosomes in the perinuclear area of bcat* melanocytes. We
identified Dynlt3, a member of the cytoplasmic dynein complex,
as a downregulated component in bcat* melanocytes compared
to wild-type, and as a regulator of melanosome movement, dis-
tribution, acidity/maturation, and transfer. Our data demonstrate,
for the first time, the fundamental role of Dynlt3 in coat and skin
coloration.
Results
Melanocytes expressing stable β-catenin display peripheral
melanosome distribution. We established melanocyte cell lines
in culture from the skin of wild-type (9v, WT) and bcat* (10d)
C57BL/6J pups. As expected, WT pigmented melanosomes
(mainly stages III and IV) were distributed uniformly throughout
the cell (Fig. 1a, b). However, melanosome localization was
markedly different in bcat* melanocytes, which displayed a
notable absence of pigmented melanosomes in the perinuclear
area (Fig. 1a), while the total number of melanosomes in WT and
bcat* cells was similar (Fig. 1b). The quantification of the number
of perinuclear melanosomes revealed that the number of pig-
mented perinuclear melanosomes was approximately three-fold
higher in WT cells compared to bcat* cells (Fig. 1c). Immuno-
fluorescence microscopy using anti-Tyrp1 antibodies- mainly
labeling stages III and IV melanosomes36—further confirmed the
reduction of pigmented melanosomes in the perinuclear area of
bcat* cells as compared to WT melanocytes (Fig. 1d and Sup-
plementary Fig. 1).
To confirm that the observed reduction of perinuclear
melanosomes in this mutant cell line was not limited to the
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specific bcat* construct, we expressed another active β-catenin
mutant, the βcat-Δex3-GFP mutant, in WT melanocytes37. This
mutant construct encodes for a β-catenin protein lacking the
serine and threonine residues that allow for its proteasomal
degradation. Similar to the bcat* cells, expression of βcat-Δex3-
GFP in WT melanocytes (WT-βcatGFP, fluorescent cells)
resulted in a reduced number of perinuclear melanosomes
compared to a GFP control (WT-GFP, fluorescent cells)
(Supplementary Fig. 2).
Pigmented melanosomes consist of stage III and IV melano-
somes. Ultrastructurally, stage III melanosomes contain dark and
thick intraluminal melanin-positive fibrils, while stage IV
melanosomes are fully filled with pigment. Melanosome matura-
tion was evaluated in WT and bcat* cells by transmission electron
microscopy (TEM). Intriguingly, pigmented bcat* melanosomes
were significantly larger than WT melanosomes (length: ≈370
vs. ≈300 nm, area: ≈71.8 vs. ≈54.3 nm2) (Supplementary Fig. 3).
β-catenin affects Dynlt3 expression. The notable peripheral
melanosome distribution in bcat* cells very likely reflected a
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exogenous expression of β-catenin. To examine this possibility,
we looked at the transcriptome of WT and bcat*melanocytes and
specifically focused on the expression of 67 genes known to be
involved in the lysosomal-related organelle (LRO) biogenesis,
transport, and maturation (Fig. 2a and Supplementary Data 1).
From these analyses, we identified Dynlt3, a member of the
cytoplasmic dynein complex, as a gene whose expression was
decreased two-fold in bcat* cells compared to WT cells.
Transcriptomic data were confirmed by RT-qPCR and western
blot analyses and showed that both Dynlt3 mRNA and protein
levels were decreased in bcat* cells, relative to WT cells (Fig. 2b, c
and Supplementary Fig. 4). These results were corroborated using
independent melanocyte cell lines established from independent
WT and bcat* pups (Supplementary Fig. 5a). The regulation of
Dynlt3 levels by β-catenin was then validated using different
approaches. We first overexpressed βcat-Δex3-GFP in WT cells,
following which Dynlt3 mRNA and protein levels were both
significantly decreased (Fig. 2d–g and Supplementary Fig. 4).
Subsequently, we knocked down β-catenin in WT cells and
observed an increase in both Dynlt3 mRNA and protein
(Fig. 2h–k). Finally, the knockdown of β-catenin in bcat*
melanocytes resulted in a similar increase in Dynlt3 mRNA and
protein levels (Fig. 2l–o and Supplementary Fig. 4), thereby
clearly demonstrating that β-catenin expression appears to have
an inhibitory effect on the levels of Dynlt3.
Knockdown of Dynlt3 in WT melanocytes phenocopies mela-
nosome distribution in bcat* melanocytes. Given that Dynlt3 is
a member of the Tctex-type 3 family of Dynein motor light chains
implicated in centripetal (retrograde) transport17,38 and that its
expression was decreased in bcat* cells, we wondered whether
Dynlt3 was a player involved in melanosome distribution. To this
end, we reduced the levels of Dynlt3 in WT melanocytes. Similar
to bcat* cells, knockdown of Dynlt3 phenocopied the exclusion of
pigmented melanosomes from the perinuclear area (Fig. 3a, b).
The number of perinuclear melanosomes was decreased two-fold
in WT-siDynlt3 cells as compared to control (Fig. 3c), while the
total number of melanosomes was unchanged (Fig. 3d). As pre-
viously, WT-siDynlt3 cells stained with an anti-Tyrp1 antibody
revealed a notable absence of staining in the perinuclear area,
which was not the case in WT-siCtrl melanocytes (Fig. 3e and
Supplementary Fig. 1).
We next treated the WT melanocytes with ciliobrevin D, an
inhibitor of the cytoplasmic dynein heavy chain, and observed a
similar phenotype to bcat* melanocytes and WT melanocytes
with decreased levels of Dynlt3. In the ciliobrevin D treated
melanocytes, pigmented melanosomes were primarily localized at
the cell periphery and were notably less numerous in the
perinuclear area (Fig. 3f).
While the ciliobrevin treatment did not affect the total number
of melanosomes in WT cells (Fig. 3g), the quantification of the
number of perinuclear melanosomes revealed that there was a
two-fold decrease in the number of perinuclear pigmented
melanosomes when the WT cells were treated with ciliobrevin
D (Fig. 3h).
Thus, loss of Dynlt3 in WT melanocytes mimics the effects of
disruption of the dynein heavy chain, with respect to pigmented
melanosome localization.
Finally, to confirm the role of Dynlt3 in rescuing the abnormal
melanosome phenotype, we overexpressed Dynlt3 in bcat*
melanocytes (Fig. 4a), which, while not affecting the total number
of pigmented melanosomes (Fig. 4b), resulted in the redistribu-
tion of the pigmented melanosomes in the perinuclear area
(Fig. 4c, d).
Decreased Dynlt3 amounts increased melanosome motility. We
next examined potential alterations in melanosome motility using
time-lapse video microscopy to track pigmented melanosome
movement (Supplementary Videos 1 and 2). Direct observation of
melanosome movements revealed that motion is generally com-
posed of variable and intermittent movement, with a high level of
pauses followed by short bursts of movements, as previously
reported39,40.
The movement of melanosomes in bcat* cells was enhanced
when compared with WT melanosomes. On average, the total
distance that bcat* melanosomes traveled was longer than WT
melanosomes (24.0 vs. 11.8 μm, Fig. 5a, b). The average distance
and velocity of bcat* melanosomes were also increased compared
to WT melanosomes (Supplementary Fig. 6a, b). Similarly, βcat-
Δex3-GFP WT cells showed increased total distance traveled by
melanosomes relative to WT cells expressing GFP alone (21.4 vs.
11.1 μm, Fig. 5a, b). The average distance and velocity of
melanosomes in βcat-Δex3-GFP-expressing WT cells were also
higher than in control GFP-expressing WT cells (Supplementary
Fig. 6a, b). Additionally, following transfection with GFP or βcat-
Δex3-GFP, we monitored the trajectories of melanosomes in non-
transfected cells (i.e., GFP-negative cells). The total distance that
the melanosomes traveled on average in these non-transfected
cells (GFP or βcat-Δex3-GFP) was similar to WT cells (11.8 vs.
11.0 vs. 11.3 μm, respectively, Fig. 5a, b). Taken together, β-
catenin exogenous expression increased the movement of
melanosomes.
We also examined the directionality of the tracked melano-
somes, with respect to the centrifugal and centripetal movement
(Supplementary Fig. 6c, d). While melanosomes in WT cells
moved centrifugally and centripetally with similar frequencies
(51% centrifugal and 49% centripetal), significantly, bcat*
melanosomes more frequently moved centrifugally (71% cen-
trifugal vs. 29% centripetal). Similarly, βcat-Δex3-GFP WT
melanosomes moved more centrifugally than centripetally
(68% vs. 32%, respectively), whereas melanosomes in control
Fig. 1 Melanosomes are distributed at the periphery of melanocytes expressing activated β-catenin. a Brightfield and inverse brightfield images of WT
(9v) and bcat* (10d) melanocytes. In WT cells, 94.1% of cells in culture exhibit a uniform distribution of melanosomes throughout the cell, with only 2.3%
of cells having melanosomes absent from the perinuclear area. In contrast, in bcat* cultures, 88.5% of cells show an altered distribution of pigmented
melanosomes, with 9.7% of cells having melanosomes evenly distributed throughout the cell. Note that some melanocytes did not have any pigmented
melanosomes. Bar, 20 μm. b Quantification of the total number of pigmented melanosomes in WT and bcat* melanocytes. Results represent the mean ±
the standard deviation (SD) of pooled data from three independent biological experiments with a total of nineteen WT and fourteen bcat* cells. ns signifies
no statistical significance (p= 0.686) as determined by the two-sided Mann–Whitney test. c Quantification of the number of perinuclear pigmented
melanosomes in WT and bcat* melanocytes. Results represent the mean ± SD of pooled data from three independent biological experiments with a total
of nineteen WT and fourteen bcat* cells. Statistical significance was determined by the two-sided Mann–Whitney test. **** signifies p < 0.0001.
d Immunofluorescence analysis of WT and bcat* melanocytes. Cells were processed for immunofluorescence and stained with anti-Tyrp1 (red) antibodies
and the nuclei were stained with DAPI (blue). Note that Tyrp1 staining was also observed in compartments adjacent to the nucleus, which is most likely the
protein that is being synthesized and processed in the Golgi/ER. In Supplementary Fig. 1, more examples are shown. Bar, 20 μm.
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GFP-transfected WT cells moved centrifugally and centripetally
with similar frequencies (47% vs. 53%, respectively).
Downregulation of Dynlt3 in WT melanocytes stably expres-
sing shRNA targeting this gene resulted in a significant decrease
of Dynlt3 and an increase in the total distance melanosomes
traveled compared to shCtrl cells (17.9 vs. 11.9 μm, Fig. 5a, b).
This was accompanied by an increased average distance and
average velocity of melanosomes (Supplementary Fig. 6a, b).
Consistently, the Euclidean distance traveled by the melanosomes
was increased after overexpression of β-catenin or downregula-
tion of Dynlt3 (Fig. 5c).
In accordance, while melanosomes in WT-shCtrl cells moved
centrifugally and centripetally with similar frequencies (54%
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cells more frequently moved centrifugally (69% centrifugal vs.
31% centripetal) (Supplementary Fig. 6c, d).
To further characterize the melanosome movement, the
percentage of pausing melanosomes was determined by con-
sidering the number of frames where no movement was recorded.
An observed pausing melanosome can be the result of move-
ments below the resolution limit of the microscope, a biological
lack of movement of the melanosome, or the equal, yet opposite
tug-of-war action of opposing molecular motors, leading to a
perceived lack of movement. Tracked melanosomes in bcat*,
WT-βcat-Δex3 or WT-shDynlt3 cells paused less frequently than
controls (Fig. 5b, d), showing together that Dynlt3, through βcat
expression, contributes, at the very least, to the intracellular
dynamics of pigmented melanosomes.
Finally, we assessed whether the increased movement of
melanosomes in bcat* cells was microtubule-dependent by
treating WT and bcat* cells with 10μM of nocodazole (NOC)
for 1 h to depolymerize the microtubules and then assessed
melanosome movement. Interestingly, treatment with nocodazole
significantly decreased melanosome movement in bcat* cells, as
both the total distance and the Euclidean distance were decreased
compared to the DMSO control (Fig. 5e, f). Consistently, the
percentage of paused melanosomes was increased following
nocodazole treatment compared to the DMSO control (Fig. 5g).
Nocodazole treatment also decreased the total distance melano-
somes traveled and increased the percentage of paused melano-
somes in WT cells, but not the Euclidean distance (Fig. 5e–g).
However, the effects of nocodazole were more pronounced in
bcat* cells compared to WT cells. Thus, the increased movement
of melanosomes in bcat* cells appears to be dependent on
microtubules.
Mathematical and statistical analyses reveal an increase in
directional melanosome movement after reduction of Dynlt3
levels. Displacement of an object can be generated by a super-
position of various elementary processes: Brownian movement
(diffusion) as a basic process, with the potential addition of
directional movement, elastic tethering (flexible attachment to a
fixed point), and/or confinement. Noise analysis (e.g., tracking
error) also has to be taken into account for the analysis of
experimental trajectories (see Supplementary Note 1). In the
context of a general approach aimed to identify the elementary
physical processes involved in melanosome movement41, we
quantified the proportion of trajectories that were directional
during the time interval of our observation.
We focused on a descriptor referring to the classical analysis of
the Mean-square displacement (MSDðτÞ ¼ <½rðt þ τÞ  rðtÞ2>),
where r(t) is the position at a given time t and τ is the time
interval used to calculate the displacement. Here, the MSD was fit
with bτα and α, the MSD exponent, was taken as our main
descriptor (Fig. 6a, α cumulative distribution function, cdf). In the
case of purely 2D diffusive motion, MSDðτÞ ¼ 4Dτ (D diffusion
coefficient, ideal case without analysis noise), while for purely
directional movement, MSDðτÞ ¼ V2τ2 (V velocity). We pre-
viously studied the distribution of α for different simple
generating processes41 and as expected, the α distribution was
centered around 1 for diffusive processes. However, in cells, the
likelihood that organelles move in a diffusive manner is low. For
α < 1, the movement could be considered as tethering or confined
processes. Such processes were widely reported for organelle
movements due to transient interactions, confinement, or
cytoplasmic crowding42–44, but also for the addition of a
Gaussian noise41, corresponding, for example, to tracking or
analysis noise45,46. For α > 1, the movement is directional and it is
important to note that the higher the value of α (when α > 1), the
more the movement is directional. Here, this analysis was used to
bring to light differences in the proportion of the trajectories that
showed significant directional movement within the time scale of
our observation (5 min). Analysis of the α distributions in WT-
shDynlt3 and WT-shCtrl cells showed melanosome movement
was more directional in cells with decreased Dynlt3 levels, as the
α distribution was shifted significantly to the right in WT-
shDynlt3 cells compared to WT-shCtrl cells (Fig. 6a). Similarly,
there was a statistically significant difference between the α
distributions of WT and bcat* cells and between WT-GFP and
WT- βcat-Δex3-GFP cells (Supplementary Fig. 7), with the
melanosomes in cells overexpressing β-catenin displaying more
directional movement.
To further characterize the movement of melanosomes, we used
a second descriptor, the second moments of trajectories, to generate
small [S] and large [L] amplitude subpopulations (Fig. 6b). To do
so, we used Brownian movement as a mathematical reference,
which is shown to enhance the visualization of right- and left-
shifted distributions corresponding to these directional and non-
directional trajectories, respectively41. The frontier was chosen such
that L mainly corresponded to a homogeneous, directional (D)
population, and S to a non-directional (ND) population (Fig. 6c, d
and Supplementary Notes 1, 2), with trajectories between the two
lines defining an error bar. The number of directional trajectories
(out of 75 trajectories) was estimated to be 13–19 (17–25%) for WT,
compared to 57–61 (76–81%) for bcat*; 12–16 (16–21%) for WT-
GFP compared to 50–52 (67–69%) for WT-βcat-Δex3-GFP
(Supplementary Fig. 7); and 32–41 (43–55%) for WT-shCtrl
compared to 53–61 (71–81%) for WT-shDynlt3 (Fig. 6e). This
illustrates that the downregulation of Dynlt3 or the expression of
Fig. 2 Dynlt3 is downregulated after β-catenin expression. a Expression profile of 67 genes associated with the trafficking of melanosomes and other
lysosome-related organelles (LRO). Data were obtained from Affymetrix mRNA transcriptomic analyses and is presented as the ratio of expression of bcat*
cells to WT cells. b RT-qPCR analysis of Dynlt3 mRNA levels in WT and bcat* melanocytes, done from five independent biological experiments. *p=
0.0197. cWestern blot analysis of Dynlt3 protein levels in WT and bcat* melanocytes. **p= 0.0064. d, e RT-qPCR analysis of β-catenin (d) and Dynlt3 (e)
expression in WT melanocytes following transfection with the βcat-Δex3-GFP (βcat) expression vector or a GFP control. *p= 0.0104 (d) and ***p=
0.0002 (e). f Western blot of βcat and Dynlt3 levels in WT melanocytes following transfection with the βcat-Δex3-GFP (βcat) expression vector or a GFP
control. g Quantification of the Dynlt3 western blot data presented in f. *p= 0.0213. h, i RT-qPCR analysis of β-catenin (h) and Dynlt3 (i) expression in WT
melanocytes following transfection with either a control siRNA or siRNA targeting β-catenin. *p= 0.0167 (h) and **p= 0.0053 (i). j Western blot of βcat
and Dynlt3 levels in WT melanocytes following transfection with either a control (Ctrl) siRNA or siRNA targeting β-catenin. k Quantification of the Dynlt3
western blot data presented in j. *p= 0.0387. l, m RT-qPCR analysis of β-catenin (l) and Dynlt3 (m) expression in bcat* melanocytes following transfection
with either a control siRNA or siRNA targeting β-catenin, done from five independent biological experiments. ****p < 0.0001 (l) and *p= 0.0498 (m).
n Western blot of βcat and Dynlt3 levels in bcat* melanocytes following transfection with either a control siRNA or siRNA targeting β-catenin. o
Quantification of the Dynlt3 western blot data presented in n. **p= 0.0088. All statistical significance was determined using unpaired two-sided t-tests.
For all quantifications, the data is presented as the mean ± SD. Unless otherwise stated, all quantifications of the data were done from three independent
biological experiments.
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active β-catenin both leads to a significant increase of directional
trajectories.
Overexpression of β-catenin or reduction of Dynlt3 diminishes
melanosome deacidification and transfer. Melanosome acidity,
which is one indication of melanosome maturation, was evaluated
in cells expressing different amounts of Dynlt3. Non-fully mature
melanosomes are more acidic than mature melanosomes. In this
context, the number of acidic and pigmented melanosomes was
approximately two-fold higher in bcat* cells relative to WT cells
(17.2 vs. 7.0 acidic melanosomes/field), as well as in WT-siDynlt3
vs. WT-siCtrl (16.8 vs. 8.4) (Fig. 7a and Supplementary Fig. 8).
Melanocytes with increased β-catenin or decreased Dynlt3
levels harbored more pigmented and peripheral melanosomes,
which would represent an ideal subpopulation of pigment
granules to be transferred to keratinocytes. However, their change
in pH might reflect a failure to acquire transfer capacity5. We thus
examined whether these cells would have a deficiency in
melanosome transfer and consequently on coat color. Indeed,
the hairs of bcat* C57BL/6J mice were lighter than WT C57BL/6J
mice (Fig. 7b). Melanosome transfer was evaluated by co-
culturing WT, bcat*, WT-shCtrl, and WT-shDynlt3 melanocytes
in the presence of Balb/c MK keratinocytes for 10 days prior to
immunofluorescence analysis using plakoglobin (keratinocyte
marker) and Hmb45 (a melanosome marker labeling the
intraluminal melanin-positive fibrils) (Supplementary Fig. 9a,
b). We then counted the number of keratinocytes in which we
could detect at least one Hmb45-positive structure; this number
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(Fig. 7c, d). In addition, we further confirmed that melanosome
transfer was decreased in bcat* and shDynlt3 melanocytes after
FACS analysis (Fig. 7e, f and Supplementary Fig. 9c).
Taken together, these data suggest that in melanocytes with
stable, activated β-catenin or in those with diminished expression
of Dynlt3, both melanosome acidity and transfer are negatively
affected.
Discussion
In this study, we showed that in melanocytes derived from
transgenic mice expressing active β-catenin (bcat* cells), pig-
mented melanosomes were primarily absent from the perinuclear
area and localized at the cell periphery. Notably, the expression of
Dynlt3, a member of the cytoplasmic dynein complex, was
downregulated in bcat* cells, and knockdown of Dynlt3 in WT
melanocytes phenocopied the peripheral localization of pig-
mented melanosomes and their absence from the perinuclear
area. Melanosome movement was increased and melanosomes
moved in a more directional manner in cells with diminished
levels of Dynlt3. Decreased levels of Dynlt3 resulted in more
acidic melanosomes that were associated with a reduction of
melanosome transfer to keratinocytes. Altogether, these results
show that Dynlt3 is a key player in regulating melanosome
movement, acidity, and transfer. As a target of β-catenin, our
results reveal a function for the Wnt/β-catenin signaling pathway
during melanocyte and skin pigmentation.
Dynlt3 is a component of the cytoplasmic dynein complex, a
macromolecular protein complex that is essential for the trans-
port of cargos from the cell periphery towards the nucleus17,38.
While the heavy chain (Dync1h1) of this complex has an ATPase
activity and interacts with the microtubules, the light inter-
mediate (Dync1li1 and Dync1li2) and the light chains, including
Dynlt3, along with dynactin, a dynein-interacting cofactor, and
activator, are thought to have a role in cargo recognition. Despite
previous studies have shown that various virus capsid proteins
(e.g., papilloma and herpes) interact with Dynlt3 and hijack the
Cytoplasmic Dynein complex to reach the nucleus of infected
cells47,48, this work is the first to functionally demonstrate that
Dynlt3 is involved in the intracellular trafficking of an organelle.
To date, transgenic mice with melanocyte-specific mutations in
cytoplasmic dyneins have neither been identified nor produced
and therefore the role of Dynlt3 in mouse pigmentation remains
unknown. However, transgenic mice containing heterozygous
mutations in Dync1h1, which encodes the dynein heavy chain
Dync1h1, have been produced. In general, these mice show
defects in motor functions, with motor neuron degeneration and/
or sensory neuropathy observed49–52. Yet, no obvious coat color
phenotypes were reported in these heterozygous mice. Impor-
tantly, homozygous Dync1h1 mice are not viable and die during
embryonic development or shortly after birth. Therefore, whether
a coat color phenotype would be observable in homozygous mice
but would not be apparent in heterozygous mice remains
unknown. Conditional mouse mutants would be required to
answer this point, using for instance the Tyr::Cre mice53.
While mutations in DYNLT3 are not significantly detailed in
human disease, reduction of DYNLT3 protein has been observed
in late-stage Parkinson’s disease; however, whether or not
decreased levels of DYNLT3 protein have a role in Parkinson’s
disease or whether they are simply the result of the disease’s
progression remains unclear54. Interestingly, recent epidemiolo-
gical studies have suggested that patients with Parkinson’s disease
have a higher risk of developing melanoma, and vice versa55.
PARKIN, which is frequently mutated in young-onset Parkin-
son’s disease, is also downregulated in melanoma, providing a
molecular link between these two diseases56. However, to the best
of our knowledge, an association between DYNLT3 and mela-
noma has not been demonstrated. Further studies will have to be
performed to evaluate whether DYNLT3 protein levels are
decreased in melanoma, at least in the context of melanoma
patients with Parkinson’s. Intriguingly, a recent study demon-
strated that the levels of DYNLT3 protein were elevated in
ovarian epithelial lesions and that high levels of DYNLT3 mRNA
were related to decreased overall survival and progression-free
survival57.
Microarray analyses of LRO trafficking genes demonstrated
that among the components associated with cytoplasmic dynein,
only Dynlt3 levels were altered in response to β-catenin expres-
sion, suggesting that only Dynlt3 is a target of β-catenin. Inter-
estingly, the Dynlt3 promoter contains four putative Tcf/Lef
Fig. 3 Melanosomes are distributed primarily at the periphery of melanocytes when Dynlt3 levels are decreased. a Brightfield and inverse brightfield
images of WT cells transfected with either siControl or siDynlt3. Ctrl means control. In WT-siScr cells, 93.6% of cells in culture exhibit a uniform
distribution of melanosomes throughout the cell, with only 2.1% of cells having melanosomes absent from the perinuclear area. In contrast, in WT-siDynlt3
cultures, 50.5% of cells show an altered distribution of pigmented melanosomes, with 44.7% of cells having melanosomes evenly distributed throughout
the cell. Bar, 20 μm. bWestern blot analysis of Dynlt3 levels in WT cells transfected with siControl (Ctrl) or siDynlt3. Relative quantification of the western
blot analysis was performed from three independent biological experiments, and the mean ± SD is shown. Statistical significance was determined using
unpaired two-sided t-tests. ***p= 0.0003. c Quantification of the number of perinuclear pigmented melanosomes in WT melanocytes transfected with
siCtrl or siDynlt3. Results represent the mean ± SD of pooled data from three independent biological experiments with a total of nineteen WT-siCtrl and 21
WT-siDynlt3 cells. Statistical significance was determined by the two-sided Mann–Whitney test, ****p < 0.0001. d Quantification of the total number of
pigmented melanosomes in WT melanocytes transfected with siCtrl or siDynlt3. Results represent the mean ± SD of pooled data from three independent
biological experiments with a total of 19 WT-siCtrl and 21 WT-siDynlt3 cells. Statistical significance was determined by the two-sided Mann–Whitney test,
ns: not significant, p= 0.7683. e Immunofluorescence analysis of WT melanocytes transfected with siCtrl or siDynlt3. Cells were processed for
immunofluorescence 48 h after transfection and stained with anti-Tyrp1 (red) antibodies. Nuclei were stained with DAPI (blue). Note that Tyrp1 staining
was also observed in compartments adjacent to the nucleus, which is most likely the protein that is being synthesized and processed in the Golgi/ER. In
Supplementary Fig. 1, more examples are shown. Scale bar, 20 μm. f Brightfield images of WT cells treated with either dimethyl sulfoxide (DMSO) or 80
μM ciliobrevin D for 6 h, after which 9.6% of WT ciliobrevin-treated cells and 1.8% of DMSO-treated cells have decreased perinuclear melanosomes. Bar,
20 μm. g Quantification of the total number of pigmented melanosomes in WT melanocytes treated with DMSO or 80 μM ciliobrevin (Cilio) for 6 h.
Results represent the mean ± SD of pooled data from three independent biological experiments with a total of 15 cells for each condition. ns signifies no
statistical significance (p= 0.9759) as determined by the two-sided Mann–Whitney test. h Quantification of the number of perinuclear pigmented
melanosomes in WT melanocytes treated with DMSO or 80 μM ciliobrevin for 6 h. Results represent the mean ± SD of pooled data from three
independent biological experiments with a total of 15 cells for each condition. Statistical significance was determined by the two-sided Mann–Whitney test
and **** signifies p < 0.0001.
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binding sites, suggesting that β-catenin may be involved in the
regulation of Dynlt3 transcription. Importantly, our results
identify Dynlt3 as a β-catenin target and one whose expression is
negatively regulated by β-catenin. However, we cannot exclude
that knockdown of other dynein complex members may have a
similar effect on melanosome localization. Importantly, in WT
and bcat* cells, Dynlt1, the other member of the Tctex light chain
family, was not expressed (Supplementary Fig. 5b), in agreement
with previous studies showing that Dynlt1 and Dynlt3 are not
expressed in the same tissue24,25. Whether other cytoplasmic
dynein subunits affect melanosome localization, and which ones,
in particular, do so, are currently under investigation.
Video microscopy and manual tracking showed that melano-
some movement is not constantly directional. Instead, the
direction that melanosomes moved changed consistently, with
melanosomes often going forward and backward repeatedly.
Melanosome movement in both WT and bcat* cells was sig-
nificantly inhibited following treatment with nocodazole, which
was consistent with previous reports showing decreased mela-
nosome motility in Xenopus melanophores and mouse RPE cul-
tures following nocodazole treatment9,40,58–61.
The downregulation of Dynlt3 resulted in a more directed
movement. On microtubules, the back and forth movement of
melanosomes can be thought of as competitions between the
kinesin and dynein motors. While this random movement
would be energetically costly and seemingly inefficient62, this
back and forth movement may occur to allow melanosomes to
mature properly without passing onto the actin microfilaments
and being transferred before they are fully mature. Furthermore,
these types of melanosome saltations in different directions,
which are characterized by rapid bursts of movement inter-
spersed with pauses, are thought to be important for the proper
homogenous distribution of melanosomes in the cytoplasm and
could be useful for helping them avoid potential traffic jams on
microtubules9,58,63.
To our knowledge, this work is the first indication that defects
in cytoplasmic dynein have an impact on melanosome transfer.
That decreased Dynlt3 levels diminished melanosome transfer is
somewhat perplexing since pigmented melanosomes localized
primarily at the cell periphery, and were ideally positioned to be
further transferred. However, in cells that expressed less Dynlt3,
melanosomes were more acidic, as more pigmented melanosomes
accumulated acridine orange. In addition, in bcat* cells, mela-
nosomes were larger and more acidic than WT melanosomes.
This is coherent and we hypothesize that this occurs since the
bcat* melanosomes were not able to de-acidy their lumens and
remove the materials which are supposed to remain in melano-
cytes before the mature melanosomes are transferred to kerati-
nocytes, including melanogenic enzymes such as tyrosinase and
Tyrp1. Since melanosomes de-acidify their lumen before being
transferred to keratinocytes, and since increased acidity is an
indication of immature melanosomes, our data suggest that
Dynlt3 has some role in the regulation of melanosome maturity,
or at the very least, in the deacidification of the melanosome
lumen. Recently, it has been shown that the maturation of mel-
anosomes before transfer involves the formation and release of
membrane tubules containing proteins (e.g., Vamp7) that are
needed to tune melanosome homeostasis (including the pH and
melanin content) and ultimately their secretory capacity5. The
separation of these tubules from the mature melanosome requires
proteins involved in membrane scission (e.g., Myosin 6, Opti-
neurin), whose downregulation results in increased melanosome
size and acidity. One should note that Myosin 6 was upregulated
in bcat* vs. WT melanocytes (Fig. 2a). Our hypothesis is that
since the level of Dynlt3 is reduced, the cell tries to compensate
















































Fig. 4 Overexpression of Dynlt3 redistributes melanosomes in bcat*
melanocytes. a Brightfield, inverse brightfield, and GFP images of bcat*
melanocytes transiently expressing GFP or GFP-tagged Dynlt3. Bar, 20 μm.
b Quantification of the total number of pigmented melanosomes in bcat*
melanocytes transfected with expression vector encoding GFP or GFP-
tagged-Dynlt3. Results represent the mean ± SD of pooled data from three
independent biological experiments with a total of 16 bcat*-GFP and 14
bcat*-Dynlt3-GFP cells. ns signifies no statistical significance (p= 0.5178)
as determined by the two-sided Mann–Whitney test. c Quantification of the
number of perinuclear pigmented melanosomes in bcat* melanocytes
transfected with expression vector encoding GFP or GFP-tagged-Dynlt3.
Results represent the mean ± SD of pooled data from three independent
biological experiments with a total of sixteen bcat*-GFP and fourteen bcat*-
Dynlt3-GFP cells. Statistical significance was determined by the two-sided
Mann–Whitney test and **** signifies p < 0.0001. d Immunofluorescence
analysis of bcat* melanocytes transiently expressing GFP or GFP-tagged
Dynlt3. Note the nuclear localization of Dynlt3-GFP, which has been
previously observed28. Cells were processed for immunofluorescence 48 h
after transfection and stained with anti-Tyrp1 (red) antibodies. The nuclei
were stained with DAPI (blue). In Supplementary Fig. 1, more examples are
shown. Bar, 20 μm.
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the separation of these tubules from the melanosomes. Therefore,
it is conceivable that Dynlt3 has a role in this process, possibly in
the pulling, fission, and/or the retrograde transport of the mela-
nosomal tubules, therefore contributing to melanosome matura-
tion and secretion.
Taken together, our results have, to the best of our knowledge,
identified Dynlt3 as a novel and important player in melanosome
biology (transport, acidity/maturation, and transfer) and in coat
coloration and pigmentation. Furthermore, our results suggest
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biology of different organelles, in addition to their already
established functions in organelle trafficking.
Methods
Cell culture. Immortalized mouse melanocyte cell lines established from the skin
of wild-type (WT) and bcat* Mus musculus C57BL/6J male transgenic mice have
been previously described34. Melanocyte cell lines were grown in Ham’s F12 media
(Gibco, 21765-029) supplemented with 10% FBS (Gibco, 10270-106), antibiotics
(100 U/mL penicillin and 100 μg/mL streptomycin; Gibco, 15140), and 200 nM
TPA (Sigma, P1585). Two independent wild-type (9v and 13d) and two inde-
pendent bcat* (10d and 14d) melanocyte cell lines were used for this study. The
melanocyte cell cultures contained only melanocytes, as keratinocytes do not grow
under these media conditions and fibroblasts were selected against using the
classical G418 protocol during cell line establishment. Balb/c MK mouse epidermal
keratinocytes (obtained from ATCC) were grown in Joklik Modified MEM (Sigma,
M8028) supplemented with 10% FBS, antibiotics (as above), and 5 ng/mL EGF
(Sigma, E9644). All cell lines were maintained at 37 °C in a humidified atmosphere
containing 5% CO2. All cell lines were routinely tested for mycoplasma and were all
negative.
For co-culture experiments, the melanocyte and keratinocyte cell lines were
cultured in melanocyte growth media in the presence of 200 nM TPA, 5 ng/mL
EGF, and 50 nM CaCl2. Co-culture experiments were performed with a ratio of 2:1,
keratinocytes to melanocytes, and the cells were left in co-culture for 10 days, after
which they were processed as described below. For immunofluorescence
experiments, the cells were plated on glass coverslips coated with 1 mg/mL collagen
(Sigma, C7661).
Animal care, use, and experimental procedures were conducted in accordance
with recommendations of the European Community (86/609/EEC) and Union
(2010/63/UE), and the French National Committee (87/848). Animal care and use
were approved by the ethics committee of the Curie Institute in compliance with
the institutional guidelines.
Transfection and infection of melanocyte cell lines. All cells were transfected
using the Amaxa Cell Line Nucleofector Kit L (Lonza, VCA-1005) according to the
manufacturer’s recommendations. Briefly, cells were trypsinized and counted, with
Fig. 5 Melanosome movement is increased in cells producing active β-catenin or with diminished levels of Dynlt3. Melanosome movement
(corresponding mainly to stage IV melanosome) was assessed by brightfield video microscopy over a period of 5 min and melanosome trajectories were
followed using ImageJ software. For each cell line, 75 melanosomes were followed from a minimum of nine independent cells. WT cell lines were
transfected with control GFP or β-catenin-GFP expression vectors, respectively. Analyses were performed on both transfected (i.e., GFP-positive) and non-
transfected (i.e., GFP-negative) cells. In addition, WT cells were transfected with either control or Dynlt3 shRNA vectors, and analyses were performed on
the resulting red cells. Each dot represents one melanosome. a The total distance indicates the sum of all of the individual tracks for each melanosome.
c The Euclidean distance refers to the distance between the start and end position of each melanosome. d The percentage of time that each melanosome
spent stationary/paused refers to the proportion of the number of tracks where no movement was measured compared to the total number of tracks. The
pause depends on the time and the pixel size (1 pixel = 0.16 μm). b The level of Dynlt3 in these different cell lines was evaluated after western blot analysis.
Relative quantification of the western blot analysis was performed from three to four independent biological experiments, with the mean ± SD presented. In
panel c, one outlier was removed from WT+βcat+, its value was 20 μm. To assess the role of microtubules in melanosome movement, the total distance
(e), Euclidean distance (f), and pausing melanosomes (g) were determined from 50 WT and bcat* melanosomes treated with 10 μM nocodazole (NOC)
for 1 h. For western blot analysis, all statistical significance was determined using unpaired two-sided t-tests, from a minimum of three independent
biological experiments. **p < 0.01; ***p= 0.0005. For the other analyses, statistical significance was measured using two-sided Mann–Whitney tests. ns
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Fig. 6 Increased directional movement of melanosomes in cells with increased levels of β-catenin or decreased Dynlt3. a α distributions for WT-shCtrl
(blue) and WT-shDynlt3 (red) populations of trajectories. Non-directional (ND) and directional (D). Statistical analyses were done using a Wilcoxon test.
**p < 0.01. cdf, cumulative distribution function. b μ2S, μ2L plots reflecting the extent of WT-shCtrl (b) and WT-shDynlt3 (c) trajectories. Each point
corresponds to one trajectory. Lines correspond to frontiers between ND and D trajectories: see Supplementary Note 2 for criteria and validation.
c, d Schematic representation of ND (c) and D (d) movement. The purple ellipse represents the cargo. The arrows represent the direction and the
orientation of the movement, and the length of the arrows is directly proportional to the magnitude of the movement. e Percentage of directional
trajectories for melanosomes in WT, bcat*, WT-GFP (denoted WT+GFP), WT-βcat-Δex3-GFP (denoted WT+ βcat), WT-shCtrl, and WT-shDynlt3 cells,
out of the total 75 trajectories for each population of trajectories. Cell lines depicted in blue have trajectories that are mainly non-directional, and those in
red are mainly directional. The values presented in the graph correspond to the middle values of the ranges described in the text. The same frontiers were
used for all populations (Supplementary Note 2). Error bars correspond to trajectories between the two frontiers (Fig. 6b and Supplementary Fig. 7).
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7.5 × 105 cells resuspended in the Amaxa transfection reagent. Four micrograms of
each respective plasmid or 100 pmol of siRNA were added to the mixture, which
was then transferred to a cuvette and incubated in the Amaxa nucleofector. Fol-
lowing nucleofection, the cells were added to a six-well dish containing pre-
warmed growth media. The following day, the cells were washed and incubated in
fresh growth media supplemented with TPA. Transfections were assayed 48 h
following nucleofection. Control GFP and β-catenin-GFP-tagged plasmids have
been previously described37. The Dynlt3-GFP (pCMV3-mDynlt3-GFPSpark) and
the control GFP vectors (pCMV3-GFP) were purchased from Sino Biological
(MG5A2492-ACG and CV026, respectively).
WT cells expressing a control shRNA or an shRNA against Dynlt3 (targeting
sequence: 5′-ATCAGATGTTGTATCCCAA-3′) were produced using viral particles
and Dharmacon SMARTvector plasmids (VSC11715 and V3SM11241-233912870,
respectively). Following infection, cells were selected using 1 μg/mL puromycin.
siRNA sequences. siRNA targeting mouse β-catenin and Dynlt3 were purchased
from Dharmacon as a SMARTpool mix of 4 sequences. The sequences of the
siRNA are as follows: for β-catenin: 5′-GAACGCAGCAGCAGUUUGU-3′, 5′-CA
GCUGGCCUGGUUUGAUA-3′, 5′-GCAAGUAGCUGAUAUUGAC-3′, 5′-GAU
CUUAGCUUAUGGCAAU-3′; and for Dynlt3: 5′-CCCAUAAUAUAGUCAAA
GA-3′, 5′-GGUGGUAACGAUUAUAAUG-3′, 5′-GGGGAAAGCUUACAAGUA
C-3′, 5′-CAGAGGAGCCCGUAUGGAU-3′. A random, scrambled sequence (5′-A
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Semi-quantitative real-time PCR. Total RNA was extracted from cells using the
miRNeasy kit from Qiagen (217004) according to the manufacturer’s protocol.
Reverse transcription reactions were performed with 500 ng of total RNA and M-
MLV reverse transcriptase (Invitrogen), according to the manufacturer’s instruc-
tions. The cDNA generated was then subjected to semi-quantitative real-time PCR
for the analysis of gene expression using ABI 7900HT. Oligonucleotides used for
PCR were as follows: for β-catenin, 5′-CGTGGACAATGGCTACTCAA-3′ (F) and
5′-TGTCAGCTCAGGAATTGCAC-3′ (R); for Dynlt3 5′-GCGATGAGGTTG
GCTTCAATGCTG-3′ (F) and 5′-CACTGCACAGGTCACAATGTACTTG-3′ (R);
and for Gapdh 5′-ACCCAGAAGACTGTGGATGG-3′ (F) and 5′-CACATTG
GGGGTAGGAACAC-3′ (R). F means forward. R means reverse.
Western blot analysis. Whole-cell lysates were prepared from melanocyte cell
lines using ice-cold RIPA buffer supplemented with a complete protease inhibitor
cocktail and PhosStop phosphatase inhibitor cocktail (Roche). For western blotting,
25 μg total protein was separated on 15% denaturing acrylamide SDS-PAGE gels
and the proteins transferred to nitrocellulose membranes. Membranes were
blocked in 5% non-fat milk in Tris-buffered saline supplemented with 0.05%
Tween-20 (TBST) and probed with primary antibodies overnight. The signal was
detected using peroxidase-conjugated anti-mouse or anti-rabbit secondary anti-
bodies (Jackson, 115-035-003 and 111-035-003, respectively, both used at 1:20,000)
and enhanced chemiluminescence (ECL; ThermoFisher). The primary antibodies
were used as follows: Dynlt3, 1:200 (Sigma, hpa003938), β-catenin, 1:2000 (Abcam,
ab6302), GFP, 1:500 (Institut Curie), and β-actin, 1:10,000 (Sigma, A5441).
Immunofluorescence microscopy. Melanocyte cells were seeded on 18 mm glass
coverslips and grown to confluence, after which they were washed twice with ice-
cold PBS and fixed-permeabilized with ice-cold methanol–acetone (1:1 solution)
on ice for 5 min. Next, cells were washed twice with cold PBS and blocked with a
blocking solution containing 1% BSA (w/v) and 10% FBS in PBS for 1 h at room
temperature. Cells were washed again twice with PBS and then incubated with
primary antibodies against anti-Tyrp1 (Abcam, ab3312) and anti-GFP (Institut
Curie) both at a concentration of 1:200, at 4 °C overnight. The following day, the
cells were washed again three times with PBS and then incubated with Alexa 555
anti-rabbit (ThermoFisher, A231572) or Alexa 488 anti-mouse (ThermoFisher,
A21202) secondary antibodies (1:500 for both) for 1 h at room temperature in the
absence of light. All antibodies were diluted in PBS+ 1% BSA. Cells were then
again washed two times before being counterstained with 0.5 µg/µL DAPI in PBS to
visualize the nucleus. Coverslips were then mounted on glass slides using ProLong
Gold antifade reagent (Invitrogen, P36934). Images were then taken using an
Upright widefield Leica Microscope at ×63.
For chemical inhibitor experiments, WT cells were treated with 80 μM
ciliobrevin D (Sigma, 250401) for 6 h. Cells were then washed twice with ice-cold
PBS and fixed-permeabilized with ice-cold methanol–acetone (1:1 solution) on ice
for 5 min. The cells were then stained for DAPI and mounted on coverslips as
described above. Images were then taken using an Upright widefield Leica DM6000
Microscope equipped with a ×63 oil-immersion objective. Bloc filters were used to
detect fluorescence: for DAPI, excitation was performed between 375 and 435 nm,
and emission was collected between 445 and 495 nm, for Alexa 488, excitation was
between 450 and 490 nm and emission was collected between 500 and 550 nm, and
Alexa 555, excitation was between 590 and 650 nm and emission was collected
between 663 and 738 nm. Images were obtained with an sCMOS Hamamatsu Orca
Flash camera.
For co-culture experiments, mouse-keratinocyte co-cultures were washed twice
with cold PBS and then fixed with 4% paraformaldehyde (VWR 1.04005.1000) for
20 min at room temperature. Following two, 5-min washes with PBS, the cells were
permeabilized with 0.2% v/v Triton X-100 in PBS for 10 min at room temperature.
The cells were once again washed and then processed as described above, using
anti-Hmb45 (Abcam, 787) and anti-plakoglobin (Abcam, 184919) primary
antibodies both diluted to 1:200.
Confocal images of co-cultures were acquired with a Leica SP5 inverted
confocal laser scanning microscope (CLSM), equipped with a ×63 Plan
Apochromat oil‐immersion objective. The pinhole was set to 1 AU. No zoom was
used during acquisition for co-culture experiments whereas a zoom of ×3.5 was
used for acridine orange experiments. Fluorescence emissions were detected at
575–645 nm upon excitation at 561 nm (DPSS laser) for Alexa 555, at 500–550 nm
upon excitation at 488 nm (Argon laser) for Alexa 488, and at 415–465 nm upon
excitation at 405 nm (Diode laser) for DAPI. Images were obtained with a PMT
detector.
Video microscopy and melanosome tracking. Cells were seeded in 6-well glass
plates (MatTek Corporation P06G-1.5-20-F) and were imaged using a Leica
DMI6000B inverted widefield microscope (Ratio 2) equipped with an EM-CCD
Photometrics camera. Cells were maintained at 37 °C in a humidified atmosphere
of 5% CO2 while videos were being taken. Videos were taken with a ×100 oil-
immersion objective over a period of 5 min, with one image taken every 0.5 s.
Videos were taken from a minimum of nine melanocytes per cell line/transfection
from three independent biological experiments. From these melanocytes, the tra-
jectories of 75 pigmented melanosomes were manually followed using the Manual
Tracking plugin for ImageJ64. Each melanosome path was chosen at random. The
Manual Tracking provided a number of different parameters that were used to
characterize the movement of the individual melanosomes. Namely, we calculated
the total distance the melanosomes moved, which was the sum of values for all of
the 601 frames during the 5-min videos. Note that the distance traveled is
dependent on the used time window. The Euclidean distance was calculated as the
distance between the melanosome position at the first frame and the last frame65.
The average distance was calculated as the total distance divided by the number of
frames (601). Similarly, the average velocity was calculated by taking the average
distance per frame and dividing it by the time (0.5 s). Finally, the percentage of
time the melanosomes were paused was calculated by assessing the number of
frames (out of the 601 total frames) where a “0” value was recorded for the distance
traveled. Using the Ratio 2 video microscope, the size of each pixel was 0.16 μm,
and therefore, in our analyses, movements below this size were considered to be
static. Therefore, an observed paused melanosome can be the result of movements
below the resolution limit of the microscope, a biological lack of movement of the
melanosome or the equal, yet opposite tug-of-war action of opposing molecular
motors, leading to a perceived lack of movement. The distribution of spatio-
temporal descriptors of trajectories, in particular mean-square displacement
characteristics, was computed and compared to simulated trajectories in order to
distinguish directional vs. non-directional movements (ref. 41 and Supplementary
Notes 1 and 2). Tracking was done blindly by two different individuals.
For video microscopy following nocodazole treatment, WT and bcat* cells were
incubated in 10 μM nocodazole (Sigma, M1404) for 1 h at 37 °C. Videos were then
taken in a humidified atmosphere of 5% CO2 at 37 °C.
Melanosome number and localization quantification. Brightfield photo-
micrographs of melanocytes were obtained with an upright widefield Leica
DM6000 microscope. Using the default threshold of the ImageJ Analyze Particle
feature, we selected pigmented structures with a size greater than or equal to
150 nm in order to estimate the apparent number of pigmented melanosomes/cell.
Albino melanocyte melan-c was used as a non-pigmented reference. To examine
perinuclear melanosomes, we used a DAPI image of each cell of interest to establish
the perinuclear area. Specifically, using the edge of the nucleus as a starting point,
we considered an area that was 2 μm extended from the border of the nucleus. The
number of perinuclear melanosomes in this “nuclear-extended” boundary region
was then counted and normalized to the total area of the boundary region. In the
Fig. 7 Melanosome acidity and transfer are altered in cells producing active β-catenin or with a diminished level of Dynlt3. a Quantitation of acridine
orange positive melanosomes in WT, bcat*, WT+ siCtrl, and WT+ siDynlt3 cells from five independent biological experiments. ***p= 0.0007 (WT vs.
bcat*) and 0.0001 (WT+ siCtrl vs. WT+ siDynlt3), as determined by unpaired, two-sided t-tests. Nb, number. b Photograph of wild-type and bcat* 2-
month-old adult male mice and of their respective dorsal hairs. c Quantitation of the percentage of Pmel and Plakoglobin double-positive cells in co-
cultures of WT or bcat* cells with Balb/c MK keratinocytes, as assessed by confocal microscopy. Pmel positivity was assessed as being either positive or
negative within each respective keratinocyte (Ker). Quantitation was done from three biologically independent co-culture experiments. ***p= 0.0004, as
determined by an unpaired, two-sided t-test. d Quantitation of the percentage of Pmel and Plakoglobin double-positive cells, in co-cultures of WT cells
expressing either control or Dynlt3 shRNA, with Balb/c MK keratinocytes, as assessed by confocal microscopy. Pmel positivity was assessed as being
either positive or negative within each respective keratinocyte (Ker). Quantitation was done from three biologically independent co-culture experiments.
***p= 0.0005, as determined by an unpaired, two-sided t-test. e FACS analysis of Hmb45 and plakoglobin positive cell populations in WT and bcat*
melanocytes. f Quantitation of melanosome transfer assayed by FACS. WT, bcat*, WT-shCtrl, or WT-shDynlt3 melanocytes were co-cultured with Balb/c
MK mouse keratinocytes for 10 days, after which the co-cultures were fixed and processed for FACS analyses using Hmb45 and Plakoglobin (Pg)
antibodies. The percentage of Plakoglobin and Hmb45 double-positive cells within each respective co-culture is presented. Quantitation was done from a
minimum of four biologically independent co-culture experiments. For all quantitations, the mean ± SD is shown. *p= 0.0260 (WT vs. bcat*) and 0.0286
(WT-shCtrl vs. WT-shDynlt3), as determined by an unpaired, two-sided t-test.
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case where some of the regions extended outside of the cell, this area was sub-
tracted from the area used for quantification. Quantification of melanosome
numbers and localization was done blindly by two different individuals.
Flow cytometry. For all flow cytometry experiments, cells were trypsinized and the
resulting cell pellets were resuspended and fixed in 4% paraformaldehyde for
20 min at room temperature. Following centrifugation, the cell pellets were then
washed twice with PBS containing 1% BSA and 0.1% saponin (Sigma, S4521). Cells
were then incubated in primary antibodies against Hmb45 and plakoglobin (both
at 1:100) for 2 h at 4 °C while rocking in the absence of light. Next, cell pellets were
washed once with PBS/BSA/saponin and incubated in Alexa 647 rabbit (Ther-
moFisher A31573) and Alexa 488 mouse secondary antibodies (at 1:500) for 1 h.
Cells were then washed in PBS and resuspended in PBS+ 0.1% azide. Flow
cytometric analyses were performed using a BD FACSCanto II machine.
Melanosome acidity. Cells were seeded in 35 mm imaging dishes (Ibidi, 81156)
and allowed to reach ~75% confluence. Acridine orange (Sigma, A6014) was added
to the cells at 20 μg/mL and incubated for 20 min at 37 °C. The cells were then
incubated in warm PBS and imaged using a confocal microscope. To look at
acridine orange staining, fluorescence emissions were detected at 590–660 nm upon
excitation at 458 nm (Argon laser)66. Melanosome acidity was assessed by counting
the number of pigmented melanosomes that were positive for acridine orange
staining. This was done by merging the brightfield and acridine orange signals. The
number of melanocytes assessed per field of view was always kept constant.
Electron microscopy. Melanocytes seeded on coverslips were chemically fixed in
2.5% (v/v) glutaraldehyde, 2% (v/v) paraformaldehyde in 0.1 M cacodylate buffer
for 24 h at 4 °C, post-fixed with 1% (w/v) osmium tetroxide supplemented with
1.5% (w/v) potassium ferrocyanide, dehydrated in ethanol and embedded in
Epon67. Ultrathin sections of cell monolayers or tissue were prepared with a
Reichert UltracutS ultramicrotome (Leica Microsystems) and contrasted with
uranyl acetate and lead citrate. Electron micrographs were acquired on a Tecnai
Spirit electron microscope (FEI, Eindhoven, The Netherlands) equipped with a 4k
CCD camera (EMSIS GmbH, Münster, Germany). The area of the melanosomes
was determined as the length * width * π. Measurements were done blindly by two
different individuals.
Statistics and reproducibility. The details of statistical tests and the number of
replicates for each experiment are provided in the figure legends and in the
“Methods” section. The data were analyzed using GraphPad Prism. The values in
the graphs represent the mean of at least three independent biological experiments,
with error bars representing the standard deviation (SD). Any p-value inferior to
0.05 was considered to be statistically significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The Affymetrix transcriptomic data generated during this study have been deposited in
the NCBI GEO and are available under the accession number GSE167268. All numerical
source data for the main figures are included in this published article’s Supplementary
Data 2 file.
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